Table 1 Frequencies of nominal study parameters during acute COVID-19 and at the two follow-ups.
Neurological symptoms | Fatigue | Sleep disturbance | |||||
|---|---|---|---|---|---|---|---|
n (valid %) | missing | n (valid %) | missing | n (valid %) | missing | ||
Acute | Total | 18 (52.9) | 0 | 33 (100) | 1 | 20 (60.6) | 1 |
Male | 13 (52.0) | 0 | 24 (100) | 1 | 15 (60.0) | 0 | |
Female | 5 (55.6) | 0 | 9 (100) | 0 | 5 (62.5) | 1 | |
FU1 | Total | 6 (20.0) | 4 | 16 (53.3) | 4 | 11 (36.7) | 4 |
Male | 6 (27.3) | 3 | 11 (50.0) | 3 | 6 (27.3) | 3 | |
Female | 0 (0) | 1 | 5 (62.5) | 1 | 5 (62.5) | 1 | |
FU2 | Total | 8 (27.6) | 5 | 9 (31.0) | 5 | 13 (46.4) | 6 |
Male | 3 (14.3) | 4 | 5 (23.8) | 4 | 7 (35.0) | 5 | |
Female | 5 (62.5) | 1 | 4 (50.0) | 1 | 6 (75.0) | 1 | |